Impilo invests in Swedish HIV diagnostics company Cavidi
Impilo has invested in a 29% stake in Cavidi AB, an Uppsala-based diagnostics company focused on HIV Viral Load monitoring. Cavidi has developed a new fully automated viral load diagnostic platform. This platform, Ziva™, aims to meet the need for cost-effective monitoring in high-disease burden countries.“We launched development of the Ziva platform with a loan from the European Investment Bank, our first institutional capital. We have now largely completed Ziva development and established a distribution agreement with a top 10 global diagnostic company. With this financing, we have